Arctic Vision
PrivateLast Round
Series B
Mar 9, 2021
Total Funding Raised
$132M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Arctic Vision operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B round in March 2021.
Arctic Vision is a biotechnology company that develops and commercializes innovative ophthalmic therapies and medical devices for retinal diseases, dry eye, and ocular neuroprotection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arctic Vision Comparables
Compare Arctic Vision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AffaMed Therapeutics | 90% | |
| Eluminex Biosciences | 84% | |
| Ocumension Therapeutics | 82% |
For institutional investors. Book with your work email.
Arctic Vision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 9, 2021 | ||||
| Series A | Jul 13, 2020 | ||||
| Seed | May 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Arctic Vision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series B |
| Morningside Ventures | Series B, Series A |
| Nan Fung Life Sciences | Series B, Series A, Seed |
| Nan Fung Group | Series B, Series A |
| Octagon Capital Advisors | Series B |
| Octagon Capital | Series B |
| Pivotal bioVenture Partners China | Series B, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 66% MoM.
- Jan 17, 2025
Attended Hurun Global Gazelles 2024 and received an award.
For institutional investors. Book with your work email.
Arctic Vision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Arctic Vision's valuation, stock price, and market status.
Is Arctic Vision a public or private company?
Arctic Vision is a private company.
What is the current stock price of Arctic Vision?
Arctic Vision is a private company, so its shares have no public market price. Caplight tracks Arctic Vision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arctic Vision worth (valuation)?
Valuation information for Arctic Vision is not publicly available.
Can I buy Arctic Vision stock?
Arctic Vision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arctic Vision's last funding round?
Arctic Vision's most recent funding round was Series B on March 9, 2021.
Who are the main investors in Arctic Vision?
Key investors in Arctic Vision include Loyal Valley Capital, Morningside Ventures, Nan Fung Life Sciences, Pivotal bioVenture Partners China.
Will Arctic Vision IPO soon?
No public IPO plans have been announced for Arctic Vision.
How can I track Arctic Vision secondary market activity?
Caplight tracks bids, offers, and trades in Arctic Vision's shares on secondary markets.